“Long-Term Efficacy of Omalizumab in Patients With Conventional Treatment-Resistant Vernal Keratoconjunctivitis”. Revista Alergia México 65, no. 2 (July 4, 2018): 192–196. Accessed September 23, 2026. https://www.revistaalergia.mx/ojs/index.php/ram/article/view/292.